KalVista Pharmaceuticals (KALV) 2025 Conference Transcript

KalVista Pharmaceuticals (KALV) 2025 Conference May 07, 2025 11:30 AM ET Speaker0 Well, good morning, everybody. We're still running on time. So, thanks for joining us for day one for the Citizens Life Science Conference. My name is John Wallabin, senior analyst here. And we're pleased to have Brian Palaiko from Clavista Pharmaceuticals joining us. This is a company that we initiated coverage on earlier this year. We've been covering the hereditary angioedema space for quite some time, and I think this is o ...